Business Context and Reporting Period
Company: WRAP TECHNOLOGIES, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: August 20, 2025
Reporting Period: Events occurring on August 18, 2025, and August 20, 2025.
The Company, incorporated in Delaware and trading on the Nasdaq Capital Market under the symbol "WRAP," reported the formal creation of a new class of preferred stock following a private placement agreement.
Key Financial Metrics and Capital Structure
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, or operating margins. The filing focuses exclusively on capital structure changes.
- Series B Convertible Preferred Stock Issued: 4,500 shares.
- Stated Value: $1,000 per share (Total stated value: $4,500,000).
- Par Value: $0.0001 per share.
- Conversion Terms: Initially convertible into up to 3,000,000 shares of Common Stock.
- Initial Conversion Price: $1.50 per share.
- Warrants Issued: Warrants to purchase up to 3,000,000 shares of Common Stock.
- Warrant Exercise Price: $1.50 per share.
Material Changes
The primary material change reported is the amendment to the Company's capital structure through the filing of the Certificate of Designations of Series B Preferred Stock with the Delaware Secretary of State on August 20, 2025. This action formalized the terms of a Securities Purchase Agreement entered into on August 18, 2025, with accredited investors. The issuance is subject to obtaining requisite stockholder approval.
Outlook, Risks, and Contingencies
Contingencies: The sale of the Series B Preferred Stock and accompanying warrants is explicitly subject to obtaining the requisite stockholder approval. Until such approval is granted, the transaction remains conditional.
Management Commentary: The filing references the full text of the Series B Certificate of Designations (Exhibit 3.1) for complete terms, noting that the summary provided in the 8-K is not exhaustive.
Risks: The filing does not explicitly list new risk factors beyond the standard contingency of stockholder approval for the private placement.
Investor Verification Checklist
- Verify the status of the requisite stockholder approval required to finalize the Series B issuance.
- Review the full text of the Certificate of Designations (Exhibit 3.1) for specific conversion mechanics, liquidation preferences, and voting rights not detailed in the summary.
- Confirm the final closing date of the private placement and the actual cash proceeds received, if any, post-approval.
- Assess the potential dilution impact of the 3,000,000 convertible shares and 3,000,000 warrant shares on existing common stockholders.